Osmotica Pharmaceuticals plc (OSMT:NASDAQ) Investor Relations Material

Overview

Osmotica Pharmaceuticals plc is a biopharmaceutical company dedicated to developing and selling specialty products in the neurology and women's health space, as well as non-promoted complex formulations of generic drugs. With a focus on improving patients' lives, the company is fully integrated, from manufacturing to commercialization, and offers a diverse product portfolio.

Annual Reports

Frequently Asked Questions

What is Osmotica Pharmaceuticals plc's ticker?

Osmotica Pharmaceuticals plc's ticker is OSMT

What exchange is Osmotica Pharmaceuticals plc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Osmotica Pharmaceuticals plc's headquarters?

They are based in Bridgewater, New Jersey

How many employees does Osmotica Pharmaceuticals plc have?

There are 201-500 employees working at Osmotica Pharmaceuticals plc

What is Osmotica Pharmaceuticals plc's website?

It is https://www.osmotica.com/

What type of sector is Osmotica Pharmaceuticals plc?

Osmotica Pharmaceuticals plc is in the Healthcare sector

What type of industry is Osmotica Pharmaceuticals plc?

Osmotica Pharmaceuticals plc is in the Biotechnology industry

Who are Osmotica Pharmaceuticals plc's peers and competitors?

The following five companies are Osmotica Pharmaceuticals plc's industry peers:

- Biohaven Pharmaceutical Company

- Curis Inc

- Selecta Biosciences

- Eloxx Pharmaceuticals, Inc.

- Immunic